Programme

Session 1: Epidemiology of HIV Resistance   
Resistance issues in HIV prophylaxis 
M. Wainberg
 
Session 2: HIV-1 Subtypes & HIV-2 Resistance          
Clinical implications of HIV-2 resistance   
R. Camacho
 
Session 3: Resistance to Current Antiretroviral Drugs
Management of PI/r failures      
A.M. Geretti
 
Session 4: Resistance to New Antiretroviral Drugs     
New class inhibitors       
J. Este
 
Session 5: Diagnostic Technology & Interpretation Approaches          
Ultra sensitive resistance technologies    
R. Schuurman
 
Round Table: Viral Tropism Assays      
Pathogenesis in viral tropism in HIV       
E. Arts
Technical problems and interpretation tools         
R. Kaiser

Session 6: Resistance to Hepatitis B and C   
Resistance perceptive of Hepatitis B/C (in clinical practice)
S. Mauss
 
Session 7: Clinical Implications of HIV Resistance     
Treatment prediction based on drug history          
B. Shafer
 
Round Table: Clinical Application of Susceptibility Assays           
Clinical use of resistance phenotyping      
B. Shafer
Clinical validation of geno2pheno - how to use cut-offs     
H. Walter